Variant report

Variant	esv10579
Chromosome Location	chr6:25045015-25053354
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr6:25050583-25050982	K562	blood:	n/a	n/a
2	BATF	chr6:25050667-25050928	GM12878	blood:	n/a	n/a
3	BCL11A	chr6:25050675-25050886	GM12878	blood:	n/a	n/a
4	BHLHE40	chr6:25050724-25050923	GM12878	blood:	n/a	n/a
5	BHLHE40	chr6:25047393-25047501	GM12878	blood:	n/a	n/a
6	CEBPB	chr6:25052519-25052747	MCF-7	breast:	n/a	n/a
7	CEBPB	chr6:25045516-25045837	IMR90	lung:	n/a	chr6:25045667-25045678
8	CEBPB	chr6:25045519-25045730	H1-hESC	embryonic stem cell:	n/a	chr6:25045667-25045678
9	CEBPB	chr6:25050353-25050911	IMR90	lung:	n/a	chr6:25050706-25050719
10	CEBPB	chr6:25052474-25052829	MCF-7	breast:	n/a	n/a
11	CEBPB	chr6:25045535-25045826	K562	blood:	n/a	chr6:25045667-25045678
12	CEBPB	chr6:25045498-25045847	HepG2	liver:	n/a	chr6:25045667-25045678
13	CHD1	chr6:25051764-25051803	GM12878	blood:	n/a	n/a
14	CHD1	chr6:25047380-25047499	GM12878	blood:	n/a	n/a
15	CHD2	chr6:25047319-25047414	GM12878	blood:	n/a	n/a
16	CHD2	chr6:25050782-25050959	GM12878	blood:	n/a	n/a
17	CTCF	chr6:25050840-25050990	HPAF	blood vessel:	n/a	n/a
18	CTCF	chr6:25050700-25050850	HPF	lung:	n/a	n/a
19	CTCF	chr6:25050860-25051010	AG04450	lung:	n/a	n/a
20	CTCF	chr6:25050760-25050910	HCPEpiC	choroid plexus:	n/a	n/a
21	CTCF	chr6:25050740-25050890	AG04450	lung:	n/a	n/a
22	CTCF	chr6:25050740-25050890	SAEC	small airway:	n/a	n/a
23	CTCF	chr6:25050780-25050930	HMF	breast:	n/a	n/a
24	CTCF	chr6:25050700-25050850	HUVEC	blood vessel:	n/a	n/a
25	CTCF	chr6:25050676-25050967	IMR90	lung:	n/a	n/a
26	CTCF	chr6:25050780-25050930	HUVEC	blood vessel:	n/a	n/a
27	CTCF	chr6:25050720-25050870	AG09319	gingival:	n/a	n/a
28	CTCF	chr6:25050740-25050890	NHDF-neo	bronchial:	n/a	n/a
29	CTCF	chr6:25050740-25050890	HPAF	blood vessel:	n/a	n/a
30	CTCF	chr6:25052400-25052550	SAEC	small airway:	n/a	n/a
31	CTCF	chr6:25050740-25050890	HEK293	kidney:	n/a	n/a
32	CTCF	chr6:25050740-25050890	AG04449	skin:	n/a	n/a
33	CTCF	chr6:25050700-25050850	AG09319	gingival:	n/a	n/a
34	CTCF	chr6:25050760-25050910	AG04449	skin:	n/a	n/a
35	CTCF	chr6:25050740-25050890	HCPEpiC	choroid plexus:	n/a	n/a
36	CUX1	chr6:25047329-25047486	GM12878	blood:	n/a	n/a
37	EBF1	chr6:25047213-25047578	GM12878	blood:	n/a	chr6:25047432-25047443
38	EBF1	chr6:25050675-25050880	GM12878	blood:	n/a	n/a
39	EBF1	chr6:25047146-25047713	GM12878	blood:	n/a	chr6:25047432-25047443
40	EGR1	chr6:25050675-25050942	K562	blood:	n/a	chr6:25050837-25050850
41	EGR1	chr6:25050718-25050980	K562	blood:	n/a	chr6:25050837-25050850 chr6:25050961-25050976
42	EP300	chr6:25050728-25050967	GM12878	blood:	n/a	n/a
43	EP300	chr6:25050677-25050888	SK-N-SH_RA	brain:	n/a	chr6:25050697-25050711 chr6:25050698-25050712 chr6:25050696-25050710
44	EP300	chr6:25050591-25050993	GM12878	blood:	n/a	chr6:25050697-25050711 chr6:25050698-25050712 chr6:25050696-25050710
45	EP300	chr6:25050399-25051126	SK-N-SH	brain:	n/a	chr6:25050697-25050711 chr6:25050482-25050496 chr6:25050698-25050712 chr6:25050696-25050710
46	EP300	chr6:25047347-25047375	GM12878	blood:	n/a	n/a
47	EP300	chr6:25050656-25050989	SK-N-SH_RA	brain:	n/a	chr6:25050697-25050711 chr6:25050698-25050712 chr6:25050696-25050710
48	EP300	chr6:25047316-25047516	GM12878	blood:	n/a	n/a
49	FOS	chr6:25050599-25050946	MCF10A-Er-Src	breast:	n/a	chr6:25050774-25050781 chr6:25050776-25050785 chr6:25050775-25050785 chr6:25050774-25050786 chr6:25050774-25050785
50	FOS	chr6:25050585-25050955	MCF10A-Er-Src	breast:	n/a	chr6:25050774-25050781 chr6:25050776-25050785 chr6:25050775-25050785 chr6:25050774-25050786 chr6:25050774-25050785

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:25050788-25050838	PFSK-1	brain:	n/a
2	chr6:25050788-25050838	AG04449	skin:	fetal
3	chr6:25050788-25050838	CMK	blood:	n/a
4	chr6:25050788-25050838	HCT-116	colon:	n/a
5	chr6:25050788-25050838	HL-60	blood:	n/a
6	chr6:25050788-25050838	ProgFib	skin:	n/a
7	chr6:25050788-25050838	GM12878	blood:	n/a
8	chr6:25050788-25050838	ovcar-3	ovarian:	n/a
9	chr6:25050788-25050838	Hela-S3	cervix:	n/a
10	chr6:25050788-25050838	GM19239	blood:	n/a
11	chr6:25050788-25050838	HCF	heart:	n/a
12	chr6:25050788-25050838	MCF10A-Er-Src	breast:	n/a
13	chr6:25050788-25050838	HCM	heart:	n/a
14	chr6:25050788-25050838	HCPEpiC	choroid plexus:	n/a
15	chr6:25050788-25050838	SK-N-SH_RA	brain:	n/a
16	chr6:25050788-25050838	HPAEpiC	pulmonary alveolar:	n/a
17	chr6:25050788-25050838	HIPEpiC	eye:	n/a
18	chr6:25050788-25050838	NHBE	bronchial:	n/a
19	chr6:25050788-25050838	NH-A	brain:	n/a
20	chr6:25050788-25050838	BE2_C	brain:	n/a
21	chr6:25050788-25050838	NHDF-neo	bronchial:	n/a
22	chr6:25050788-25050838	MCF-7	breast:	n/a
23	chr6:25050788-25050838	AoSMC	blood vessel:	n/a
24	chr6:25050788-25050838	AG10803	skin:	n/a
25	chr6:25050788-25050838	HMEC	breast:	n/a
26	chr6:25050788-25050838	HEEpiC	esophagus:	n/a
27	chr6:25050788-25050838	HepG2	liver:	n/a
28	chr6:25050788-25050838	BJ	skin:	n/a
29	chr6:25050788-25050838	NT2-D1	testis:	n/a
30	chr6:25050788-25050838	IMR90	lung:	fetal
31	chr6:25050788-25050838	SAEC	small airway:	n/a
32	chr6:25050788-25050838	GM06990	blood:	n/a
33	chr6:25050788-25050838	HAEpiC	amniotic membrane:	n/a
34	chr6:25050788-25050838	NB4	blood:	n/a
35	chr6:25050788-25050838	Jurkat	blood:	n/a
36	chr6:25050788-25050838	GM12891	blood:	n/a
37	chr6:25050788-25050838	AG09309	skin:	n/a
38	chr6:25050788-25050838	ECC-1	luminal epithelium:	n/a
39	chr6:25050788-25050838	HRE	kidney:	n/a
40	chr6:25050788-25050838	PANC-1	pancreas:	n/a
41	chr6:25050788-25050838	HRCEpiC	kidney:	n/a
42	chr6:25050788-25050838	SK-N-SH	brain:	n/a
43	chr6:25050788-25050838	SKMC	muscle:	n/a
44	chr6:25050788-25050838	HEK293	kidney:	embryo
45	chr6:25050788-25050838	PrEC	prostate:	n/a
46	chr6:25050788-25050838	LNCaP	prostate:	n/a
47	chr6:25050788-25050838	HNPCEpiC	eye:	n/a
48	chr6:25050788-25050838	Caco-2	colon:	n/a
49	chr6:25050788-25050838	K562	blood:	n/a
50	chr6:25050788-25050838	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:25044748..25046790-chr6:25120372..25122694,2	K562	blood:

Variant related genes	Relation type
ENSG00000272053	TF binding region
FAM65B	TF binding region
ENSG00000272053	CpG island
FAM65B	CpG island

Extended variants
information (count: 348 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:348 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562805049	chr6:25045028-25045029	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs531512794	chr6:25045118-25045119	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs145885598	chr6:25045122-25045123	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs138492364	chr6:25045126-25045127	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs561010401	chr6:25045224-25045225	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs34475409	chr6:25045237-25045238	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs547574934	chr6:25045252-25045253	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs149190205	chr6:25045253-25045254	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs539485098	chr6:25045270-25045271	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs303905	chr6:25045277-25045278	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs570419321	chr6:25045282-25045283	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs114202305	chr6:25045290-25045291	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs11759312	chr6:25045305-25045306	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs76964543	chr6:25045311-25045312	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs368724606	chr6:25045327-25045328	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs189847694	chr6:25045361-25045362	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs143361881	chr6:25045362-25045363	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs571516783	chr6:25045373-25045374	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs540320118	chr6:25045381-25045382	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs386698140	chr6:25045384-25045385	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs13200401	chr6:25045385-25045386	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
22	rs13214630	chr6:25045396-25045397	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs13214631	chr6:25045398-25045399	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs74482672	chr6:25045433-25045434	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs181125593	chr6:25045442-25045443	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs13214745	chr6:25045459-25045460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs574423232	chr6:25045460-25045461	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs13214857	chr6:25045461-25045462	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs148352606	chr6:25045475-25045476	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs535567939	chr6:25045525-25045526	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs1597010	chr6:25045543-25045544	Enhancers Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs561872729	chr6:25045545-25045546	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs141443539	chr6:25045569-25045570	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs1597011	chr6:25045586-25045587	Enhancers Weak transcription	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs147488901	chr6:25045611-25045612	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs539569678	chr6:25045644-25045645	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs549732607	chr6:25045697-25045698	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs372950107	chr6:25045713-25045714	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs1597012	chr6:25045776-25045777	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs535706133	chr6:25045778-25045779	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs555834943	chr6:25045789-25045790	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs303034	chr6:25045798-25045799	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs57176515	chr6:25045804-25045805	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs200716353	chr6:25045813-25045814	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs372208367	chr6:25045814-25045815	Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs534940925	chr6:25045860-25045861	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs76941043	chr6:25045869-25045870	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs386698141	chr6:25045872-25045873	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs371391334	chr6:25045873-25045874	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs115169153	chr6:25045874-25045875	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Bladder cancer	16790693	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Lung cancer	19153074	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
Myelofibrosis	22110671	CNVD
Williams-beuren syndrome	16971481	CNVD
Uveal melanoma	20484589	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	20421269	CNVD

Chromatin state (count:159 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:25042200-25050200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr6:25043200-25053400	Weak transcription	Spleen	Spleen
3	chr6:25043400-25050800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
4	chr6:25043800-25050200	Weak transcription	Primary B cells from cord blood	blood
5	chr6:25044200-25047200	Weak transcription	Primary B cells from peripheral blood	blood
6	chr6:25044200-25050000	Weak transcription	Primary hematopoietic stem cells	blood
7	chr6:25044400-25049600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr6:25044400-25049600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr6:25044400-25049800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
10	chr6:25044600-25049600	Weak transcription	Primary T helper cells PMA-I stimulated	--
11	chr6:25044600-25049600	Weak transcription	Primary T helper cells fromperipheralblood	blood
12	chr6:25044600-25050000	Weak transcription	Primary T helper naive cells from peripheral blood	blood
13	chr6:25044800-25049800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
14	chr6:25044800-25049800	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
15	chr6:25045000-25045400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
16	chr6:25045000-25045800	Enhancers	HUES64 Cell Line	embryonic stem cell
17	chr6:25045200-25045600	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr6:25045400-25045600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
19	chr6:25045600-25047000	Weak transcription	HUES48 Cell Line	embryonic stem cell
20	chr6:25045600-25049800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
21	chr6:25046000-25062400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
22	chr6:25047200-25047800	Enhancers	Primary B cells from peripheral blood	blood
23	chr6:25047800-25049600	Weak transcription	Primary B cells from peripheral blood	blood
24	chr6:25049600-25050200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr6:25049600-25050400	Enhancers	Primary T helper cells PMA-I stimulated	--
26	chr6:25049600-25050800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr6:25049600-25058200	Enhancers	Primary T helper cells fromperipheralblood	blood
28	chr6:25049600-25059200	Enhancers	Primary B cells from peripheral blood	blood
29	chr6:25049800-25050000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
30	chr6:25049800-25050400	Enhancers	Thymus	Thymus
31	chr6:25049800-25050800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
32	chr6:25049800-25051000	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr6:25049800-25051200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
34	chr6:25049800-25051800	Enhancers	Cortex derived primary cultured neurospheres	brain
35	chr6:25049800-25056000	Enhancers	Primary hematopoietic stem cells short term culture	blood
36	chr6:25049800-25056000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
37	chr6:25050000-25050200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
38	chr6:25050000-25050200	Weak transcription	Sigmoid Colon	Sigmoid Colon
39	chr6:25050000-25050400	Enhancers	Primary hematopoietic stem cells	blood
40	chr6:25050000-25050400	Enhancers	Monocytes-CD14+_RO01746	blood
41	chr6:25050000-25051200	Enhancers	ES-I3 Cell Line	embryonic stem cell
42	chr6:25050000-25051800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
43	chr6:25050000-25052000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
44	chr6:25050000-25052200	Enhancers	Primary T helper naive cells from peripheral blood	blood
45	chr6:25050000-25052800	Enhancers	Primary T killer memory cells from peripheral blood	blood
46	chr6:25050000-25052800	Enhancers	Dnd41	blood
47	chr6:25050000-25056200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
48	chr6:25050200-25050400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr6:25050200-25050400	Enhancers	iPS-20b Cell Line	embryonic stem cell
50	chr6:25050200-25050400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links